Related Experiment Videos
[Gene therapy for colorectal cancer]
1Department of Surgery I, Faculty of Medicine, Tottori University.
Abstract:
Gene therapy represents a novel approach to the treatment of colorectal cancer, and this brief review addresses the current strategies and ongoing clinical trials, including tumor suppressor gene replacement therapy with wild-type p53, virus-directed enzyme-prodrug therapy and immunomodulatory approaches. All of the clinical trials have been phase I, principally designed to evaluate safety, but some of them provided the evidence of gene delivery and expression. Although the results of pre-clinical studies have been encouraging, clinical trials have not yet demonstrated anti-tumor effect. Gene therapy for colorectal cancer is still in the early stages of development, and fundamental research in the molecular and cellular biology will improve the therapy.
Insights
Gene therapy for colorectal cancer is under early development. Current clinical trials focus on safety, showing gene delivery but not yet anti-tumor effects, requiring further research.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Context:
- Colorectal cancer (CRC) remains a significant global health challenge.
- Novel therapeutic strategies are urgently needed to improve patient outcomes.
- Gene therapy offers a promising, albeit nascent, approach to CRC treatment.
Purpose:
- To review current gene therapy strategies for colorectal cancer.
- To examine ongoing clinical trials and their preliminary findings.
- To identify future research directions for enhancing CRC gene therapy.
Summary:
- Current CRC gene therapy strategies include tumor suppressor gene replacement (e.g., wild-type p53), virus-directed enzyme-prodrug therapy, and immunomodulatory approaches.
- Phase I clinical trials have primarily assessed safety, with some demonstrating successful gene delivery and expression.
- Pre-clinical studies show promise, but clinical trials have not yet confirmed significant anti-tumor efficacy.
Impact:
- Gene therapy for colorectal cancer is in its early developmental stages.
- Further fundamental research in molecular and cellular biology is crucial for advancing therapeutic effectiveness.
- Successful development could lead to innovative treatment options for colorectal cancer patients.